Related Experiment Videos
[Neuroleptic malignant syndrome. A case report]
L Conti1, V Molene, P G Sironi
1Servizio di Anestesia e Rianimazione, Ospedale Fatebenefratelli e Oftalmico, Milano.
Minerva Anestesiologica
|December 1, 1990
Summary
Neuroleptic Malignant Syndrome (NMS) is a rare but serious condition. Prompt treatment with dantrolene sodium and bromocriptine, alongside supportive care, can effectively manage NMS symptoms.
Area of Science:
- Neuroscience
- Pharmacology
- Critical Care Medicine
Background:
- Neuroleptic Malignant Syndrome (NMS) is a rare but life-threatening condition.
- It is characterized by a specific clinical presentation following the administration of neuroleptic medications.